Cervical carcinoma is one of the main causes of women's cancer, and substantial side effects from standard treatment including platinum-based chemotherapy limit the options for escalation. In this paper, using cervical cancer cell lines and tumor-bearing mice as models, we report that CONPs could inhibit the proliferation of cancer cells in vitro and in vivo. Especially CONPs could inhibit tumor growth as cisplatin without weight loss. CONPs could also induce autophagy through AKT/mTOR pathway, which demonstrates that CONPs has the potential clinical applications.
Cuprous Oxide Nanoparticles Inhibit the Growth of Cervical Carcinoma by Inducing Autophagy
SUNLONG BIOTECH / 2024-01-09
- Periodical：Oncotarget 8, 61083-61092 (2017)
- Article source
User Comment(Total0User Comment Num)
- No comment
+86 571 56623320
[email protected]
+86 18668110335
Scan Wechat Qrcode
